Role of Endothelial Function, Muscular Fitness and Metabolism in Functional Activity in Patients With Chronic Heart Failure (CHF)
NCT ID: NCT01139086
Last Updated: 2010-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2010-05-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. to compare muscular strength, endurance, and perfusion of quadriceps between CHF patients and healthy controls by isokinetic test and near-infrared spectroscopy (NIRS) and difference in activities of daily living
2. to compare endothelium function between CHF patients and healthy control subjects
3. the relationship between endothelium function, muscular strength, endurance, perfusion, and metabolism of quadriceps.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Aerobic Interval and Continuous Exercise Trainings in Patients With Chronic Heart Failure
NCT01229670
Peripheral Metabolic Function in Chronic Heart Failure Patients
NCT02732990
Exercise Training Effects in Patients With Heart Failure
NCT01071629
Effect of Exercise-based Rehabilitation on Circulatory Functions in Patients With Diastolic Heart Failure
NCT01053091
Effects of Rehabilitation in Patients With Stable Chronic Heart Failure
NCT03538249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cardiovascular disease
Diagnosis of cardiomyopathy or ischemic heart disease without heart failure
No interventions assigned to this group
Chronic heart failure
Diagnosis of cardiomyopathy or ischemic heart disease LVEF \<40%
No interventions assigned to this group
Control
Age and body built matched with chronic heart failure group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic heart failure: ejection fraction\<40% and at stable condition
* Coronary Disease and dilated cardiomyopathy without heart failure
* Control group without diagnosis of any heart disease
Exclusion Criteria
40 Years
75 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ying-Tai Wu, Ph.D
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201003050R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.